Mersana Therapeutics Inc (NAS:MRSN)
$ 1.985 0.145 (7.88%) Market Cap: 243.51 Mil Enterprise Value: 95.29 Mil PE Ratio: 0 PB Ratio: 28.36 GF Score: 39/100

Q4 2022 Mersana Therapeutics Inc Earnings Call Transcript

Feb 28, 2023 / 01:00PM GMT
Release Date Price: $6.06 (+11.60%)
Operator

Good morning, and welcome to Mersana Therapeutics' Fourth Quarter and Year-End 2022 Conference Call and Webcast. (Operator Instructions)

I would now like to turn the call over to Jason Fredette, Senior Vice President, Investor Relations and Corporate Communications. Please proceed.

Jason Fredette
Mersana Therapeutics, Inc. - SVP of IR & Corporate Communications

Good morning, everyone. Before we begin, please note that this call will contain forward-looking statements within the meaning of federal securities laws. These statements may include, but are not limited to, those related to the therapeutic potential of our product candidates and the potential of our platforms, business strategy, clinical trial designs, initiation, execution and data releases, regulatory plans and objectives, commercial opportunities, collaborations and potential associated payments, operating expenses and cash runway.

Each of these forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot